Chesnokova et al., has reported that excess pituitary-derived growth hormone (GH) predisposes to the development of precancerous colon polyps and colon cancer, while inactivating growth hormone receptor (GHR) mutations or GHR antagonist attenuates the development of colon cancer [40]. Here, GH1 is linked to malignant colon neoplasm.